Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
US SEC Commissioner: SEC Issued Crypto Asset ETP Disclosure Guidelines Last Week

US SEC Commissioner: SEC Issued Crypto Asset ETP Disclosure Guidelines Last Week

ForesightNewsForesightNews2025/07/08 19:51
Show original

Foresight News reports that Hester Peirce, a commissioner of the U.S. Securities and Exchange Commission (SEC), stated that last week, SEC staff released a set of guidelines to assist in preparing disclosures for crypto asset ETPs. The guidelines outline what crypto ETF issuers must include in their filings, covering detailed descriptions ranging from how to calculate net asset value and select service providers to custody practices and potential conflicts of interest. The SEC emphasized that issuers must provide targeted disclosures based on their specific structures, with a focus on asset selection, custody, conflicts of interest, and the ETF creation/redemption mechanism.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

As traditional automakers cut back on their loss-making electric vehicle businesses, Tesla (TSLA.US) has regained more than half of the US electric vehicle market share.

智通财经2026/09/14 01:06
The US EV landscape after subsidy cuts: traditional automakers cut and halt production, Tesla (TSLA.US) regains the majority share with Model Y

Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas

A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.

智通财经2026/09/14 00:46
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas